These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 31485630)

  • 21. TAGLN2 promotes the proliferation, invasion, migration and epithelial-mesenchymal transition of colorectal cancer cells by activating STAT3 signaling through ANXA2.
    Zhao Z; Lu L; Li W
    Oncol Lett; 2021 Oct; 22(4):737. PubMed ID: 34466149
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polychlorinated Biphenyl Quinones Promotes Breast Cancer Metastasis through Reactive Oxygen Species-Mediated Nuclear Factor κB-Matrix Metalloproteinase Signaling.
    Wang Y; Wang Y; Liu Z; Dong W; Yang B; Xia X; Song E; Song Y
    Chem Res Toxicol; 2018 Sep; 31(9):954-963. PubMed ID: 30080411
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cross-talk between SIM2s and NFκB regulates cyclooxygenase 2 expression in breast cancer.
    Wyatt GL; Crump LS; Young CM; Wessells VM; McQueen CM; Wall SW; Gustafson TL; Fan YY; Chapkin RS; Porter WW; Lyons TR
    Breast Cancer Res; 2019 Nov; 21(1):131. PubMed ID: 31783895
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transgelin-2 contributes to proliferation and progression of hepatocellular carcinoma via regulating Annexin A2.
    Shi J; Ren M; She X; Zhang Z; Zhao Y; Han Y; Lu D; Lyu L
    Biochem Biophys Res Commun; 2020 Mar; 523(3):632-638. PubMed ID: 31941608
    [TBL] [Abstract][Full Text] [Related]  

  • 25. BRD7 suppresses invasion and metastasis in breast cancer by negatively regulating YB1-induced epithelial-mesenchymal transition.
    Niu W; Luo Y; Zhou Y; Li M; Wu C; Duan Y; Wang H; Fan S; Li Z; Xiong W; Li X; Li G; Ren C; Li H; Zhou M
    J Exp Clin Cancer Res; 2020 Feb; 39(1):30. PubMed ID: 32028981
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Downregulation of NMI promotes tumor growth and predicts poor prognosis in human lung adenocarcinomas.
    Wang J; Zou K; Feng X; Chen M; Li C; Tang R; Xuan Y; Luo M; Chen W; Qiu H; Qin G; Li Y; Zhang C; Xiao B; Kang L; Kang T; Huang W; Yu X; Wu X; Deng W
    Mol Cancer; 2017 Oct; 16(1):158. PubMed ID: 29025423
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PinX1 inhibits the invasion and metastasis of human breast cancer via suppressing NF-κB/MMP-9 signaling pathway.
    Shi M; Cao M; Song J; Liu Q; Li H; Meng F; Pan Z; Bai J; Zheng J
    Mol Cancer; 2015 Mar; 14():66. PubMed ID: 25888829
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transgelin-2, a novel cancer stem cell-related biomarker, is a diagnostic and therapeutic target for biliary tract cancer.
    Jo JH; Park SB; Chung J; Oh T; Lee HS; Chung MJ; Park JY; Bang S; Park SW; Jung DE; Song SY
    BMC Cancer; 2024 Mar; 24(1):357. PubMed ID: 38509504
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IGJ suppresses breast cancer growth and metastasis by inhibiting EMT via the NF‑κB signaling pathway.
    Wang M; Wu Y; Li X; Dai M; Li S
    Int J Oncol; 2023 Sep; 63(3):. PubMed ID: 37539706
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cystathionine‑γ‑lyase promotes the metastasis of breast cancer via the VEGF signaling pathway.
    Wang L; Shi H; Liu Y; Zhang W; Duan X; Li M; Shi X; Wang T
    Int J Oncol; 2019 Aug; 55(2):473-487. PubMed ID: 31173185
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MiR-142-5p Acts as a Significant Regulator Through Promoting Proliferation, Invasion, and Migration in Breast Cancer Modulated by Targeting SORBS1.
    Yu W; Li D; Zhang Y; Li C; Zhang C; Wang L
    Technol Cancer Res Treat; 2019; 18():1533033819892264. PubMed ID: 31789129
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transgelin-2 is upregulated on activated B-cells and expressed in hyperplastic follicles in lupus erythematosus patients.
    Kiso K; Yoshifuji H; Oku T; Hikida M; Kitagori K; Hirayama Y; Nakajima T; Haga H; Tsuruyama T; Miyagawa-Hayashino A
    PLoS One; 2017; 12(9):e0184738. PubMed ID: 28910360
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Curcumin derivative WZ35 inhibits tumor cell growth via ROS-YAP-JNK signaling pathway in breast cancer.
    Wang L; Wang C; Tao Z; Zhao L; Zhu Z; Wu W; He Y; Chen H; Zheng B; Huang X; Yu Y; Yang L; Liang G; Cui R; Chen T
    J Exp Clin Cancer Res; 2019 Nov; 38(1):460. PubMed ID: 31703744
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cell-permeable transgelin-2 as a potent therapeutic for dendritic cell-based cancer immunotherapy.
    Kim HR; Park JS; Park JH; Yasmin F; Kim CH; Oh SK; Chung IJ; Jun CD
    J Hematol Oncol; 2021 Mar; 14(1):43. PubMed ID: 33731208
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CXCL1 derived from tumor-associated macrophages promotes breast cancer metastasis via activating NF-κB/SOX4 signaling.
    Wang N; Liu W; Zheng Y; Wang S; Yang B; Li M; Song J; Zhang F; Zhang X; Wang Q; Wang Z
    Cell Death Dis; 2018 Aug; 9(9):880. PubMed ID: 30158589
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lutein inhibits proliferation, invasion and migration of hypoxic breast cancer cells via downregulation of HES1.
    Li Y; Zhang Y; Liu X; Wang M; Wang P; Yang J; Zhang S
    Int J Oncol; 2018 Jun; 52(6):2119-2129. PubMed ID: 29620169
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification and verification of transgelin-2 as a potential biomarker of tumor-derived lung-cancer endothelial cells by comparative proteomics.
    Jin H; Cheng X; Pei Y; Fu J; Lyu Z; Peng H; Yao Q; Jiang Y; Luo L; Zhuo H
    J Proteomics; 2016 Mar; 136():77-88. PubMed ID: 26721444
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Disruption of SM22 promotes inflammation after artery injury via nuclear factor kappaB activation.
    Shen J; Yang M; Ju D; Jiang H; Zheng JP; Xu Z; Li L
    Circ Res; 2010 Apr; 106(8):1351-62. PubMed ID: 20224039
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circular RNA circIKBKB promotes breast cancer bone metastasis through sustaining NF-κB/bone remodeling factors signaling.
    Xu Y; Zhang S; Liao X; Li M; Chen S; Li X; Wu X; Yang M; Tang M; Hu Y; Li Z; Yu R; Huang M; Song L; Li J
    Mol Cancer; 2021 Jul; 20(1):98. PubMed ID: 34325714
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA-133b suppresses bladder cancer malignancy by targeting TAGLN2-mediated cell cycle.
    Zhao F; Zhou LH; Ge YZ; Ping WW; Wu X; Xu ZL; Wang M; Sha ZL; Jia RP
    J Cell Physiol; 2019 Apr; 234(4):4910-4923. PubMed ID: 30317571
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.